Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive Disorders

Area of Science:

• Neuroscience
• Biochemistry
• Infectious Disease

Background:

• Polyamines are essential for cellular functions and NMDA receptor regulation.
• Spermidine/spermine-N1-acetytransferase (SSAT) is the rate-limiting enzyme in polyamine catabolism.
• HIV-associated neurocognitive disorders (HAND) involve complex neuropathological processes, potentially including altered polyamine metabolism.

Purpose of the Study:

• To investigate abnormal polyamine cycling in HIV-infected individuals with varying degrees of HAND.
• To determine the correlation between SSAT activity, polyamine levels, and HAND severity.
• To explore the role of the HIV protein Tat in modulating polyamine metabolism.

Main Methods:

• Assessed acetyl-polyamine levels via HPLC in CSF from 99 HIV+ participants across different HAND severity groups (NCI, ANI, MCMD, HAD).
• Measured polyamine levels in brain tissues from uninfected and HIV+ individuals (NCI, MCMD).
• Evaluated SSAT activity in human primary astrocytes expressing HIV Tat in vitro.

Main Results:

• Activation of SSAT increases polyamine flux in the brain and CSF of HIV+ individuals with HAND.
• CSF acetylated polyamine levels significantly increase with HAND severity (HAD > MCMD > NCI/ANI).
• In vitro studies suggest HIV Tat contributes to astrocyte-derived acetyl polyamine release.

Conclusions:

• Polyamine metabolism alterations are implicated in the neurodegeneration observed in HAND patients.
• Changes in polyamine flux show potential as predictive diagnostic biomarkers for HAND severity.
• Targeting polyamine metabolism pathways could offer therapeutic strategies for HAND.